Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 71335-2476

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 71335-2476). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (B201c94c 128a 4ae1 86a1 057c4c895839 01)

Chemical structure of esomeprazole magnesium, showing the molecular arrangement including methyl and methoxy groups, a sulfoxide group, nitrogen atoms, and magnesium ion complexed with three water molecules.*

FDA Label Image

Figure 2: Maintenance Of Healing Rates By Month (study 177) (B201c94c 128a 4ae1 86a1 057c4c895839 02)

A line graph illustrating the percent maintained over a 6-month period for esomeprazole magnesium delayed-release capsules 40 mg and placebo groups. The graph tracks four sample groups, showing stability or decline in percent maintained, with esomeprazole groups generally maintaining higher percentages compared to placebo.*

FDA Label Image

Figure 3: Maintenance Of Healing Rates By Month (study 178) (B201c94c 128a 4ae1 86a1 057c4c895839 03)

A line chart comparing the percent maintained over six months among four groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, 10 mg, and placebo. The vertical axis shows percent maintained, and the horizontal axis shows time in months, with each dosage group showing decreasing percentages over time except the 40 mg group which remains near 100% through most months.*

FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) Figure (B201c94c 128a 4ae1 86a1 057c4c895839 04)

A line graph showing the percent of patients symptom-free over a 28-day diary period for esomeprazole magnesium delayed-release capsules at 40 mg and 20 mg doses compared to placebo. The graph tracks symptom-free percentages increasing over time, with higher percentages for both dosages versus placebo.*

FDA Label Image

Image (B201c94c 128a 4ae1 86a1 057c4c895839 05)

A line graph showing the percent of patients symptom-free over 28 diary days. It compares Esomeprazole Magnesium Delayed-Release Capsules at 40 mg and 20 mg doses versus placebo, with data points indicating symptom-free percentages increasing over time for active treatment groups compared to placebo.*

FDA Label Image

Label (Lbl713352476)

Label for Esomeprazole Magnesium delayed-release capsules, 40 mg strength. The label shows the NDC 71335-2476-1 and indicates a package size of 90 capsules. It includes manufacturer information for Graviti Pharmaceuticals Pvt. Ltd. and repackager Bryant Ranch Prepack, Inc. Dosage and storage instructions are partially visible, along with QR codes and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.